System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Nicola Scichilone is an expert in Pulmonology at University Hospital Policlinico Paolo Giaccone (Italy). As of October 2026, ScienceLeadR ranks Nicola Scichilone in the top 1% of experts worldwide for Asthma, Hypersensitivity and Lung Diseases, Obstructive. Nicola Scichilone has authored 419 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 1 of them ongoing. SLR score: 1,261 (community average: 125). How the SLR is computed.

LeadR Profile

Nicola Scichilone University Hospital Policlinico Paolo Giaccone Italy
1 261 ScienceLeadR Reputation 1261

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

University of Palermo (Italy)

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 419

Citations

Citations: 11 547 1st author: 61 Last author: 91 Unique author: 4

Main journals

Respir Med 20
J Allergy Clin Immunol Pract 18
Allergy 16
Pulm Pharmacol Ther 16
Clin Transl Allergy 14

Best Journals

Lancet Respir Med 4
N Engl J Med 2
Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Geriatric respiratory medicine 2026: from artificial intelligence to personalised management of the multimorbid patient.
PMID 42906940 — pulmonary medicine, intelligence, lung, respiratory tract diseases, therapeutics, artificial intelligence		Eur Respir Rev20260
From Quiet Asthma to Clinical Remission: Can Optimized Maximal Inhaled Therapy Achieve Biologic-Free Remission in Difficult-to-Treat and Severe Asthma?
PMID 42882216 — phenotype, therapeutics, asthma, biological therapy		J Clin Med20260
Unmet Needs and New Opportunities in Chronic Obstructive Pulmonary Disease in Italy: A Narrative Review with Insights from the GULP Study.
PMID 42831088 — eosinophils, pulmonary disease, chronic obstructive, antibodies, monoclonal, therapeutics, lung diseases, lung diseases, obstructive		Int J Chron Obstruct Pulmon Dis20260
Adherence To Inhaled Treatment Is Associated With Better Disease Control And Quality Of Life In Mild-To-Moderate Asthma.
PMID 42660367 — quality of life, therapeutics, asthma, smoking		Respir Med20260
Biologics in Older Adults with Chronic Obstructive Pulmonary Disease: A Narrative Review.
PMID 42652680 — immunosenescence, aged, pulmonary disease, chronic obstructive, therapeutics, lung diseases, frailty, biological therapy, lung diseases, obstructive		J Clin Med20260

Clinical Studies 11

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 6
Phase 3 4
Phase 4 1

By status:

Completed 9
Recruiting 2

By type:

Interventional 6
Observational 5

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 0
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 2

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
The BASA Study Breath Analysis for Severe Asthma Patients
NCT05946421 — asthma		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS